Correlation Between Nuvectis Pharma and Equillium

Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Equillium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Equillium into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nuvectis Pharma and Equillium, you can compare the effects of market volatilities on Nuvectis Pharma and Equillium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Equillium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Equillium.

Diversification Opportunities for Nuvectis Pharma and Equillium

0.39

Correlation Coefficient

Nuvectis Pharma  Equillium

Weak diversification

The 3 months correlation between Nuvectis and Equillium is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Equillium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Equillium and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Equillium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equillium has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Equillium go up and down completely randomly.

Pair Corralation between Nuvectis Pharma and Equillium

Given the investment horizon of 90 days Nuvectis Pharma is expected to under-perform the Equillium. In addition to that, Nuvectis Pharma is 2.22 times more volatile than Equillium. It trades about -0.3 of its total potential returns per unit of risk. Equillium is currently generating about -0.16 per unit of volatility. If you would invest  85.00  in Equillium on September 13, 2024 and sell it today you would lose (15.00) from holding Equillium or give up 17.65% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Nuvectis Pharma  vs.  Equillium

Nuvectis Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nuvectis Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Nuvectis Pharma is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Equillium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Equillium is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Nuvectis Pharma and Equillium

The main advantage of trading using opposite Nuvectis Pharma and Equillium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Equillium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will offset losses from the drop in Equillium's long position.

The idea behind Nuvectis Pharma and Equillium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.